Current Neuropharmacology

SJR Rank #2,068H-index: 125SJR: 1.642Best quartile: Q1

Journal website: aims, scope and author guidelines

Publisher

Bentham Science Publishers

Country

United Arab Emirates

Type

journal

SJR by Edition

Subject Categories

Medicine (miscellaneous)Q1
NeurologyQ1
Neurology (clinical)Q1
PharmacologyQ1
Pharmacology (medical)Q1
Psychiatry and Mental HealthQ1

Areas: Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neuroscience and Neuropharmacology ResearchTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesStress Responses and CortisolParkinson's Disease Mechanisms and TreatmentsTreatment of Major DepressionPain Mechanisms and Treatments

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

1875-6190, 1570-159X

SJR Best Quartile

Region

Middle East

Citations per Document (2 years)

6.36

References per Document

103.78

Coverage

2004-2026

Scope

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Metrics from SCImago Journal Rank 2025. View on SCImago